相关实验视频

Updated: Jun 11, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

作为具有抗癌活性的MMP-13抑制剂的新型Dimethylpyridine-3-Carboxamide衍生物

Remigiusz Płaczek¹, Tomasz Janek², Małgorzata Strzelecka³

¹Department of Basic Chemical Sciences, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wroclaw, Poland.

Molecules (Basel, Switzerland)

|December 31, 2025

概括

新的MMP-13抑制剂被合成和测试. 这些化合物显示选择性抑制矩阵金属蛋白酶13 (MMP-13) 和潜在的抗癌活性,提供有前途的治疗途径.

科学领域:

药用化学医学化学
生物化学生物化学
计算化学的计算化学

背景情况:

矩阵金属蛋白酶13 (MMP-13) 在各种疾病中起作用.
开发选择性MMP-13抑制剂对于向治疗至关重要.

研究的目的:

设计,合成和评估新型二甲基-3-碳胺衍生物作为选择性MMP-13抑制剂.
研究它们的结合相互作用,等离子体运输特性和体外生物活性.

主要方法:

合成和结构确认 (FT-IR,NMR,HR-MS) 进行.
光光谱检测人类血清白蛋白相互作用.
密度函数理论 (DFT) 用于电子属性.
分子对接和动力学模拟用于结合分析.
对MMP-13抑制和细胞毒性的生物评估.

主要成果:

通过光谱和质谱法方法确认的合成化合物.
化合物通过键和π堆叠与MMP-13的S1口袋呈现稳定的相互作用.
证明了MMP-13对MMP-8的选择性抑制.
对癌症细胞系表现出细胞毒性活性.
光研究提供了对等离子体运输特性的见解.

结论:

设计的二甲基胺-3-碳胺衍生物是强效和选择性的MMP-13抑制剂.
这些化合物具有有利的结合特性,并有可能用于抗癌应用.
对其治疗潜力的进一步研究是有必要的.

关键词:

MMP-13 抑制剂的使用它具有抗癌活性,具有抗癌活性.二甲基皮里丁-3-碳胺衍生物二甲基皮里丁-3-碳胺衍生物

更多相关视频

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...